Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 25.1B | 29.4B | 26.5B | 25.4B |
Cost of revenue | 16.2B | 17.8B | 15.7B | 15.4B |
Gross profit | 9.0B | 11.6B | 10.8B | 10.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 329M | 323M | 261M | 304M |
Other operating expenses | 2.9B | 2.4B | 2.4B | 2.8B |
Operating income | 5.7B | 8.9B | 8.2B | 6.9B |
Non operating interest income | ||||
Income | 303M | 336M | 286M | 460M |
Expense | 351M | 325M | -124M | 370M |
Other income expense | 95M | 22M | -427M | 274M |
Pretax income | 5.8B | 8.9B | 8.2B | 7.3B |
Tax provision | 4.4B | 6.3B | 6.2B | 5.0B |
Net income | 1.3B | 2.6B | 2.0B | 2.3B |
Basic EPS | 0.5 | 1.0 | 0.7 | 0.8 |
Diluted EPS | 0.5 | 1.0 | 0.7 | 0.8 |
Basic average shares | 2.6B | 2.7B | 2.7B | 2.8B |
Diluted average shares | 2.6B | 2.7B | 2.7B | 2.8B |
EBITDA | 9.5B | 11.5B | 11.3B | 9.7B |
Net income from continuing op. | 5.8B | 8.9B | 8.2B | 7.3B |
Minority interests | -5M | -3M | -4M | -3M |
Preferred stock dividends | — | — | — | — |